List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 66 studies with search of: rituxan CNS lymphoma | Open Studies
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma
Conditions: CNS Lymphoma;   CNS Brain Cancer;   Non-Hodgkin's Lymphoma
Intervention: Other: Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
2 Recruiting Motexafin Gadolinium, Combination Chemotherapy, Rituximab, and Whole-Brain Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
Conditions: Lymphoma;   Neurotoxicity
Interventions: Biological: rituximab;   Drug: cytarabine;   Drug: methotrexate;   Drug: motexafin gadolinium;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
3 Recruiting Methotrexate, Leucovorin, Rituximab, and Highly Active Antiretroviral Therapy in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma
Conditions: Lymphoma;   Neurotoxicity
Interventions: Biological: rituximab;   Drug: leucovorin calcium;   Drug: methotrexate;   Procedure: antiviral therapy
4 Recruiting Rituximab, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Lymphoma
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Biological: rituximab;   Drug: carboplatin;   Drug: cytarabine;   Drug: mannitol;   Drug: methotrexate;   Drug: sodium thiosulfate
5 Recruiting Rituximab, Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Sodium Thiosulfate and Cytarabine in Treating Patients With Refractory or Recurrent Primary CNS Lymphoma
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Lymphoma;   Thrombocytopenia
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Biological: rituximab;   Drug: blood-brain barrier disruption chemotherapy;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: etoposide phosphate;   Drug: sodium thiosulfate
6 Recruiting Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: methotrexate;   Drug: temozolomide;   Radiation: radiation therapy
7 Recruiting A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma
Conditions: Central Nervous System Lymphoma;   Intraocular Lymphoma
Intervention: Drug: Intraventricular Rituximab Plus MTX
8 Recruiting Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: cytarabine;   Drug: dexamethasone;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate
9 Recruiting Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma
Condition: Primary Non Hodgkin Lymphoma of the Central Nervous System
Interventions: Drug: Methotrexate;   Drug: Lomustine;   Drug: Procarbazine;   Drug: Rituximab
10 Recruiting Phase II Study for Patients With Relapsed Primary Central Nervous System Lymphoma
Condition: Lymphoma
Interventions: Drug: rituximab;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide phosphate;   Drug: cytarabine
11 Recruiting Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: bortezomib;   Drug: carboplatin;   Drug: dexamethasone;   Drug: etoposide;   Drug: ifosfamide;   Genetic: polymerase chain reaction;   Genetic: western blotting;   Other: questionnaire administration
12 Recruiting Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients
Condition: Primary Central Nervous System Lymphoma
Interventions: Radiation: cranial radiotherapy;   Drug: intensive chemotherapy and hematopoietic stem cell rescue;   Drug: MTX based chemotherapy
13 Recruiting Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: Leukemia;   Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: carboplatin;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: ifosfamide;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy;   Radiation: total-body irradiation
14 Recruiting Rituximab in Treating Patients Undergoing Stem Cell Transplant for B-Cell Cancer That Has Relapsed or Not Responded to Treatment
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous Condition;   Small Intestine Cancer
Interventions: Biological: rituximab;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Recruiting High-Dose Sequential Chemoimmunotherapy for B-Cell Lymphomas With Central Nervous System Involvement
Condition: B-Cell Lymphomas
Intervention: Drug: High-dose sequential chemotherapy and autologous transplant
16 Recruiting Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Procedure: computed tomography;   Procedure: positron emission tomography;   Procedure: radionuclide imaging;   Procedure: single photon emission computed tomography;   Radiation: tositumomab and iodine I 131 tositumomab;   Radiation: yttrium Y 90 ibritumomab tiuxetan
17 Recruiting Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: liposomal cytarabine;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate
18 Recruiting Rituximab Combined With Chemotherapy in Burkitt`s Lymphoma
Conditions: Acute Lymphoblastic Leukemia;   Burkitt's Lymphoma
Intervention: Drug: RITUXIMAB
19 Recruiting Freiburg ZNS-NHL Study
Condition: Primary Non Hodgkin Lymphoma of the Central Nervous System
Interventions: Drug: methotrexate;   Drug: Rituximab;   Drug: Cytarabine;   Drug: Thiotepa;   Drug: Carmustin
20 Recruiting Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults
Conditions: Burkitt's Lymphoma;   Burkitt's Leukemia;   Mediastinal Neoplasms;   Lymphoblastic Lymphoma;   Large Cell Anaplastic Lymphoma
Interventions: Drug: Adriamycin;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone/Prednisolone;   Drug: VP16;   Drug: Ifosfamide;   Drug: Methotrexate;   Drug: G-CSF;   Drug: Rituximab;   Drug: Vincristine/Vindesine;   Procedure: Irradiation (in specific conditions)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services